The company
Embecta Corp.
EMBC · Nasdaq
EMBC stood above a rising 150-day average in 6 of the last 52 weekly readings, and has been out of that trend for the last 41 weeks. It is 29.4% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−2 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 41
- Industry in uptrend
- 29% -2 in 4 wk
- Insider buys, 12 months
- $1.1M
- Insider sales, 12 months
- $74K
- Officials’ trades on record
- 5
- Institutions holding
- 305 (-9)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 6 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
5 disclosed lines: House 0, Senate 0, executive 5; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 30 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 30 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 26 Feb 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 26 Jan 2026filed 14 May 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Milton Mayo MorrisDirector | sold | 6,293at $5.88 | 4 Sep 2026filed 8 Sep 2026 |
| Robert J. HombachDirector | bought | 45,000at $4.97 | 12 Aug 2026filed 13 Aug 2026 |
| Jeffrey Z. MannPres, Pharm Svc&Prod Mgmt, CLO | bought | 20,000at $4.99 | 12 Aug 2026filed 13 Aug 2026 |
| Jacob ElguiczeSVP and CFO | bought | 20,000at $4.67 | 12 Aug 2026filed 13 Aug 2026 |
| Devdatt KurdikarPresident and CEO | bought | 30,000at $4.70 | 12 Aug 2026filed 13 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 4,599,771$15.0M | -4,567,441−49.8% |
| YACKTMAN ASSET MANAGEMENT LPadded · filed 11 Aug 2026 | 4,315,952$14.1M | +644,075+17.5% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 2,557,148$8.3M | -6,803−0.3% |
| DEERFIELD MANAGEMENT COMPANY, L.P.unchanged · filed 14 Aug 2026 | 2,534,961$8.3M | 00.0% |
| Jefferies Financial Group Inc.reduced · filed 17 Aug 2026 | 2,355,117$7.7M | -450.0% |
| AMERIPRISE FINANCIAL INCadded · filed 14 Aug 2026 | 2,038,731$6.6M | +1,239,043+154.9% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 1,996,747$6.5M | +1,386,943+227.4% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 1,610,666$5.3M | -935,307−36.7% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 1,594,457$5.2M | +128,810+8.8% |
| BRIGADE CAPITAL MANAGEMENT, LPnew · filed 14 Aug 2026 | 1,516,453$4.9M | +1,516,453 |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.